chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Dyspnoea, Hypersensitivity, Injection site pain
Clinical narrative: THROAT SENSATION LIKE TICKLE; COUGH; SHORTNESS OF BREATH; LIGHT PRESSURE ON CHEST; FELT LIKE HAVING AN ALLERGY; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 33 year old female. The patient's height, and weight were not reported. The patient's past medical history included anxiety, and endometriosis, and concurrent conditions included alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no drug abuse or illicit drug usage. The patient experienced watery eyes when treated with ibuprofen. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced injection site pain. On 10-APR-2021, the subject experienced throat sensation like tickle. On 10-APR-2021, the subject experienced cough. On 10-APR-2021, the subject experienced shortness of breath. On 10-APR-2021, the subject experienced light pressure on chest. On 10-APR-2021, the subject experienced felt like having an allergy. On 12-APR-2021, Laboratory data included: COVID-19 virus test negative (NR: not provided) Negative. Laboratory data (dates unspecified) included: Laparoscopy (NR: not provided) unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from felt like having an allergy, throat sensation like tickle, and injection site pain, and had not recovered from cough, shortness of breath, and light pressure on chest. This report was non-serious.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Laparoscopy, SARS-CoV-2 test negative, Throat irritation
Clinical narrative: THROAT SENSATION LIKE TICKLE; COUGH; SHORTNESS OF BREATH; LIGHT PRESSURE ON CHEST; FELT LIKE HAVING AN ALLERGY; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 33 year old female. The patient's height, and weight were not reported. The patient's past medical history included anxiety, and endometriosis, and concurrent conditions included alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no drug abuse or illicit drug usage. The patient experienced watery eyes when treated with ibuprofen. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced injection site pain. On 10-APR-2021, the subject experienced throat sensation like tickle. On 10-APR-2021, the subject experienced cough. On 10-APR-2021, the subject experienced shortness of breath. On 10-APR-2021, the subject experienced light pressure on chest. On 10-APR-2021, the subject experienced felt like having an allergy. On 12-APR-2021, Laboratory data included: COVID-19 virus test negative (NR: not provided) Negative. Laboratory data (dates unspecified) included: Laparoscopy (NR: not provided) unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from felt like having an allergy, throat sensation like tickle, and injection site pain, and had not recovered from cough, shortness of breath, and light pressure on chest. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: SORENESS OF ARM; MILD HEADACHE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced soreness of arm. On APR-2021, the subject experienced mild headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the mild headache and soreness of arm was not reported. This report was non-serious. This case, from the same reporter is linked to 20210430098.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Chills, Fluid retention, Headache, Hyperhidrosis
Clinical narrative: SWEATING; BACK OF KNEES FEEL SWOLLEN AND PUFFY AND PILLOWY; CHILLS; LEG PAIN; FEVER; HEADACHE; NUMBNESS AND TINGLING IN BACK TO CALF/KNEE; ACHY; BLOATING; WATER RETENTION; This spontaneous report received from a patient concerned a 34 year old female. The patient's height, and weight were not reported. The patient's past medical history included progressive macular hypomelanosis, and concurrent conditions included seasonal allergy, and hazelnut allergy/almond allergy, and other pre-existing medical conditions included patient had not pregnant at the time of reporting. The patient was previously treated with amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate for progressive macular hypomelanosis, and cetirizine hydrochloride for progressive macular hypomelanosis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 041A21A, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 16:00 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced achy. On 12-APR-2021, the subject experienced bloating. On 12-APR-2021, the subject experienced water retention. On 12-APR-2021 19:00, the subject experienced numbness and tingling in back to calf/knee. On 12-APR-2021 19:00, the subject experienced sweating. On 12-APR-2021 19:00, the subject experienced back of knees feel swollen and puffy and pillowy. On 12-APR-2021 19:00, the subject experienced chills. On 12-APR-2021 19:00, the subject experienced leg pain. On 12-APR-2021 19:00, the subject experienced fever. On 12-APR-2021 19:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from leg pain, numbness and tingling in back to calf/knee, and back of knees feel swollen and puffy and pillowy, and the outcome of fever, chills, achy, headache, sweating, bloating and water retention was not reported. This report was non-serious.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Pain, Pain in extremity, Paraesthesia, Pyrexia
Clinical narrative: SWEATING; BACK OF KNEES FEEL SWOLLEN AND PUFFY AND PILLOWY; CHILLS; LEG PAIN; FEVER; HEADACHE; NUMBNESS AND TINGLING IN BACK TO CALF/KNEE; ACHY; BLOATING; WATER RETENTION; This spontaneous report received from a patient concerned a 34 year old female. The patient's height, and weight were not reported. The patient's past medical history included progressive macular hypomelanosis, and concurrent conditions included seasonal allergy, and hazelnut allergy/almond allergy, and other pre-existing medical conditions included patient had not pregnant at the time of reporting. The patient was previously treated with amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate for progressive macular hypomelanosis, and cetirizine hydrochloride for progressive macular hypomelanosis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 041A21A, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 16:00 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced achy. On 12-APR-2021, the subject experienced bloating. On 12-APR-2021, the subject experienced water retention. On 12-APR-2021 19:00, the subject experienced numbness and tingling in back to calf/knee. On 12-APR-2021 19:00, the subject experienced sweating. On 12-APR-2021 19:00, the subject experienced back of knees feel swollen and puffy and pillowy. On 12-APR-2021 19:00, the subject experienced chills. On 12-APR-2021 19:00, the subject experienced leg pain. On 12-APR-2021 19:00, the subject experienced fever. On 12-APR-2021 19:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from leg pain, numbness and tingling in back to calf/knee, and back of knees feel swollen and puffy and pillowy, and the outcome of fever, chills, achy, headache, sweating, bloating and water retention was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19
Clinical narrative: SUSPECTED COVID-19 INFECTION (LEG PAIN, HEADACHE, BACK PAIN, TIREDNESS WHEN SPEAKING); This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced suspected covid-19 infection (leg pain, headache, back pain, tiredness when speaking). Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from suspected covid-19 infection (leg pain, headache, back pain, tiredness when speaking). This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Ultrasound scan
Clinical narrative: SEVERE LEG PAIN; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform  follow up to request batch number/Lot number. No concomitant medications were reported. On an unspecified date, the subject experienced severe leg pain. Laboratory data (dates unspecified) included: Sonogram (NR: not provided) Negative. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severe leg pain was not reported. This report was non-serious.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Pain
Clinical narrative: BODY ACHES; HEADACHE; LOSS OF APPETITE; CHILLS; FEVER; EXTREME FATIGUE; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A,  expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 15:00 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced extreme fatigue. On 11-APR-2021, the subject experienced loss of appetite. On 11-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced body aches. On 12-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, loss of appetite, extreme fatigue, chills, body aches, and headache. This report was non-serious.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: BODY ACHES; HEADACHE; LOSS OF APPETITE; CHILLS; FEVER; EXTREME FATIGUE; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A,  expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 15:00 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced extreme fatigue. On 11-APR-2021, the subject experienced loss of appetite. On 11-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced body aches. On 12-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, loss of appetite, extreme fatigue, chills, body aches, and headache. This report was non-serious.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Night sweats, Pain assessment
Clinical narrative: HEADACHES/PAIN AT THE BACK OF THE HEAD AND BASE OF THE SKULL 3 EPISODES; MILD NAUSEA EXPERIENCED IT 4 TIMES LAST WEEK AND LAST NIGHT; INCREASED SALIVA/MEDIUM AMOUNT OCCURS DURING NAUSEA EPISODE ONLY; SWEATINESS OCCURRED ONLY AT NIGHT, STATED THAT SHE WOKE UP WITH A WET T-SHIRT IN A COLD SWEAT; CHILLS OCCURRED ONLY AT NIGHT AT THE SAME TIME AS THE FEVER; RIGHT ARM SORENESS; FEVER/FELT HOT; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's past medical history included blood clot in leg, and concurrent conditions included hypertension, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. Concomitant medications included diazepam, and fluoxetine hydrochloride. On APR-2021, Laboratory data included: Pain scale (NR: not provided) 5-6/10. On 01-APR-2021, the subject experienced increased saliva/medium amount occurs during nausea episode only. On 01-APR-2021, the subject experienced sweatiness occurred only at night, stated that she woke up with a wet t-shirt in a cold sweat. On 01-APR-2021, the subject experienced chills occurred only at night at the same time as the fever. On 01-APR-2021, the subject experienced right arm soreness. On 01-APR-2021, the subject experienced fever/felt hot. On 01-APR-2021, the subject experienced mild nausea experienced it 4 times last week and last night. On 03-APR-2021, the subject experienced headaches/pain at the back of the head and base of the skull 3 episodes. Laboratory data included: Pain scale (NR: not provided) 8/10. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweatiness occurred only at night, stated that she woke up with a wet t-shirt in a cold sweat, chills occurred only at night at the same time as the fever, right arm soreness, and fever/felt hot on 03-APR-2021, had not recovered from mild nausea experienced it 4 times last week and last night, and increased saliva/medium amount occurs during nausea episode only, and the outcome of headaches/pain at the back of the head and base of the skull 3 episodes was not reported. This report was non-serious.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Salivary hypersecretion
Clinical narrative: HEADACHES/PAIN AT THE BACK OF THE HEAD AND BASE OF THE SKULL 3 EPISODES; MILD NAUSEA EXPERIENCED IT 4 TIMES LAST WEEK AND LAST NIGHT; INCREASED SALIVA/MEDIUM AMOUNT OCCURS DURING NAUSEA EPISODE ONLY; SWEATINESS OCCURRED ONLY AT NIGHT, STATED THAT SHE WOKE UP WITH A WET T-SHIRT IN A COLD SWEAT; CHILLS OCCURRED ONLY AT NIGHT AT THE SAME TIME AS THE FEVER; RIGHT ARM SORENESS; FEVER/FELT HOT; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's past medical history included blood clot in leg, and concurrent conditions included hypertension, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. Concomitant medications included diazepam, and fluoxetine hydrochloride. On APR-2021, Laboratory data included: Pain scale (NR: not provided) 5-6/10. On 01-APR-2021, the subject experienced increased saliva/medium amount occurs during nausea episode only. On 01-APR-2021, the subject experienced sweatiness occurred only at night, stated that she woke up with a wet t-shirt in a cold sweat. On 01-APR-2021, the subject experienced chills occurred only at night at the same time as the fever. On 01-APR-2021, the subject experienced right arm soreness. On 01-APR-2021, the subject experienced fever/felt hot. On 01-APR-2021, the subject experienced mild nausea experienced it 4 times last week and last night. On 03-APR-2021, the subject experienced headaches/pain at the back of the head and base of the skull 3 episodes. Laboratory data included: Pain scale (NR: not provided) 8/10. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweatiness occurred only at night, stated that she woke up with a wet t-shirt in a cold sweat, chills occurred only at night at the same time as the fever, right arm soreness, and fever/felt hot on 03-APR-2021, had not recovered from mild nausea experienced it 4 times last week and last night, and increased saliva/medium amount occurs during nausea episode only, and the outcome of headaches/pain at the back of the head and base of the skull 3 episodes was not reported. This report was non-serious.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Burning sensation, Dry skin, Fatigue, Headache
Clinical narrative: BURNING LEGS; HIVES AND WELTS ON BILATERAL LOWER LEGS; DRY LEGS; ITCHY LEGS; TIREDNESS; HEADACHE; MILD FEVER; BUMPS AND SMALL RED DOTS; This spontaneous report received from a patient concerned a 34 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced bumps and small red dots. On 09-APR-2021, the subject experienced tiredness. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced mild fever. Laboratory data included: Body temperature (NR: not provided) 99.6. On 10-APR-2021, the subject experienced dry legs. On 10-APR-2021, the subject experienced itchy legs. On 10-APR-2021, the subject experienced hives and welts on bilateral lower legs. On 14-APR-2021, the subject experienced burning legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from itchy legs, and burning legs on 15-APR-2021, tiredness, and headache on 11-APR-2021, and mild fever on 10-APR-2021, was recovering from hives and welts on bilateral lower legs, and bumps and small red dots, and the outcome of dry legs was not reported. This report was non-serious.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Rash, Urticaria
Clinical narrative: BURNING LEGS; HIVES AND WELTS ON BILATERAL LOWER LEGS; DRY LEGS; ITCHY LEGS; TIREDNESS; HEADACHE; MILD FEVER; BUMPS AND SMALL RED DOTS; This spontaneous report received from a patient concerned a 34 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced bumps and small red dots. On 09-APR-2021, the subject experienced tiredness. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced mild fever. Laboratory data included: Body temperature (NR: not provided) 99.6. On 10-APR-2021, the subject experienced dry legs. On 10-APR-2021, the subject experienced itchy legs. On 10-APR-2021, the subject experienced hives and welts on bilateral lower legs. On 14-APR-2021, the subject experienced burning legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from itchy legs, and burning legs on 15-APR-2021, tiredness, and headache on 11-APR-2021, and mild fever on 10-APR-2021, was recovering from hives and welts on bilateral lower legs, and bumps and small red dots, and the outcome of dry legs was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection, Urine analysis
Clinical narrative: URINARY TRACT INFECTION SYMPTOMS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 14-APR-2021, the subject experienced urinary tract infection symptoms. Laboratory data included: Urinalysis (NR: not provided) Unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of urinary tract infection symptoms was not reported. This report was non-serious.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: INAPPROPRIATE AGE AT VACCINE ADMINISTRATION; This spontaneous report received from a pharmacist concerned a 17 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-APR-2021, the subject experienced inappropriate age at vaccine administration. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of inappropriate age at vaccine administration was not reported. This report was non-serious.
Age: 77.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Fatigue, Headache, Injection site pain
Clinical narrative: INJECTION SITE PAIN; HEADACHE; TIREDNESS; This spontaneous report received from a patient concerned a 77 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included rheumatoid arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Non-company suspect drugs included: upadacitinib (oral, batch number: 1138391 expiry: UNKNOWN, form of admin was not reported) dose, frequency, and therapy dates were not reported for moderate to severe rheumatoid arthritis. No concomitant medications were reported. On 11-MAR-2021, the subject experienced injection site pain. On 11-MAR-2021, the subject experienced headache. On 11-MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site pain, headache, and tiredness on 11-MAR-2021. This report was non-serious. This case, from the same reporter is linked to 20210425531.
Sex: M
Vaccine: COVID19
Symptoms: Hypersomnia, Hypokinesia
Clinical narrative: TOOK 2 NAPS; SLOW MOTION; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 2021, the subject experienced took 2 naps. On 2021, the subject experienced slow motion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the took 2 naps and slow motion was not reported. This report was non-serious. This case, from the same reporter is linked to 20210432557.
Sex: U
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: HAD SUPER MIGRAINE SINCE RECEIVING THE VACCINE EVERY COUPLE OF DAYS, SPECIFICALLY AT NIGHT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 2021, the subject experienced had super migraine since receiving the vaccine every couple of days, specifically at night. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from had super migraine since receiving the vaccine every couple of days, specifically at night on 2021. This report was non-serious.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: SEVERE HEADACHES; This spontaneous report received from a parent concerned a 26 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced severe headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severe headaches was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: FLU LIKE SYMPTOMS; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 13-APR-2021, the subject experienced flu like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of flu like symptoms was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: ADVERSE EVENT; This spontaneous report received from a patient via an upspecified company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The unspecified Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced adverse event. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adverse event was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Injection site mass, Injection site pain, Pain in extremity
Clinical narrative: LUMP AT THE VACCINATION SITE; 2 INCHES BELOW THE INJECTION SITE ARM SORE/SLIGHTLY SORE WHEN LIFITING ARM UP; PAINFUL BURNING AT THE VACCINATION SITE; This spontaneous report received from a patient via an unspecified company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-APR-2021, the subject experienced lump at the vaccination site. On 08-APR-2021, the subject experienced 2 inches below the injection site arm sore/slightly sore when lifiting arm up. On 08-APR-2021, the subject experienced painful burning at the vaccination site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lump at the vaccination site, and painful burning at the vaccination site on 08-APR-2021, and was recovering from 2 inches below the injection site arm sore/slightly sore when lifiting arm up. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: 0.1ML OF JANSSEN COVID 19 VACCINE LEFT IN SYRINGE AFTER ADMINISTRATION; This spontaneous report received from a patient concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced 0.1ml of janssen covid 19 vaccine left in syringe after administration. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of 0.1ml of janssen covid 19 vaccine left in syringe after administration was not reported. This report was non-serious. This case, from the same reporter is linked to 20210420581.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Feeling abnormal, Pruritus
Clinical narrative: RED MARKS ON BOTH LEGS REFERRED TO AS LINES ON LEGS, AFFECTED BOTH LEGS, FROM THE FRONT OF SHIN TO SIDE OF CALF/ STRIATION MARKS THAT ARE SLIGHTLY RED; FELT FUNNY, KIND OF SENSATION COMING FROM THE AREA; ITCHING; This spontaneous report received from a patient concerned a 63 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-APR-2021, the subject experienced itching. On 13-APR-2021, the subject experienced felt funny, kind of sensation coming from the area. On 14-APR-2021, the subject experienced red marks on both legs referred to as lines on legs, affected both legs, from the front of shin to side of calf/ striation marks that are slightly red. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from red marks on both legs referred to as lines on legs, affected both legs, from the front of shin to side of calf/ striation marks that are slightly red, itching, and felt funny, kind of sensation coming from the area. This report was non-serious.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Feeling abnormal, Feeling drunk, Hangover
Clinical narrative: FELT HUNGOVER; LOSS OF ENERGY/DIDN'T HAD GUMPTION TO DO ANYTHING; FELT-LIKE DRUNK/BUZZED; TROUBLE GOING BACK TO SLEEP; FEELING OF LIKE BEATEN UP/ FELT DEAD; TIREDNESS; INJECTION SITE BURNING; ARM SORENESS; This spontaneous report received from a patient concerned a 59 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and batch number: 1808978 expiry: 13-JUN-2021) dose was not reported, administered on 12-APR-2021 14:00 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced injection site burning. On 12-APR-2021, the subject experienced arm soreness. On 13-APR-2021, the subject experienced trouble going back to sleep. On 13-APR-2021, the subject experienced feeling of like beaten up/ felt dead. On 13-APR-2021, the subject experienced tiredness. On 13-APR-2021 05:30, the subject experienced felt-like drunk/buzzed. On 15-APR-2021, the subject experienced felt hungover. On 15-APR-2021, the subject experienced loss of energy/didn't had gumption to do anything. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site burning, and arm soreness, had not recovered from tiredness, felt-like drunk/buzzed, felt hungover, loss of energy/didn't had gumption to do anything, and feeling of like beaten up/ felt dead, and the outcome of trouble going back to sleep was not reported. This report was non-serious.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity, Sleep disorder
Clinical narrative: FELT HUNGOVER; LOSS OF ENERGY/DIDN'T HAD GUMPTION TO DO ANYTHING; FELT-LIKE DRUNK/BUZZED; TROUBLE GOING BACK TO SLEEP; FEELING OF LIKE BEATEN UP/ FELT DEAD; TIREDNESS; INJECTION SITE BURNING; ARM SORENESS; This spontaneous report received from a patient concerned a 59 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and batch number: 1808978 expiry: 13-JUN-2021) dose was not reported, administered on 12-APR-2021 14:00 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced injection site burning. On 12-APR-2021, the subject experienced arm soreness. On 13-APR-2021, the subject experienced trouble going back to sleep. On 13-APR-2021, the subject experienced feeling of like beaten up/ felt dead. On 13-APR-2021, the subject experienced tiredness. On 13-APR-2021 05:30, the subject experienced felt-like drunk/buzzed. On 15-APR-2021, the subject experienced felt hungover. On 15-APR-2021, the subject experienced loss of energy/didn't had gumption to do anything. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site burning, and arm soreness, had not recovered from tiredness, felt-like drunk/buzzed, felt hungover, loss of energy/didn't had gumption to do anything, and feeling of like beaten up/ felt dead, and the outcome of trouble going back to sleep was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Myalgia
Clinical narrative: MUSCLE SORENESS; HEADACHE; FATIGUE; BODY ACHE; SORENESS IN ARM; CHILLS; FEVER; This spontaneous report received from a consumer concerned a 47 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced body ache. On APR-2021, the subject experienced soreness in arm. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced fatigue. Laboratory data included: Body temperature (NR: not provided) 100 F. On 11-APR-2021, the subject experienced muscle soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the soreness in arm, fever, headache, chills, body ache, fatigue and muscle soreness was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: MUSCLE SORENESS; HEADACHE; FATIGUE; BODY ACHE; SORENESS IN ARM; CHILLS; FEVER; This spontaneous report received from a consumer concerned a 47 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced body ache. On APR-2021, the subject experienced soreness in arm. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced fatigue. Laboratory data included: Body temperature (NR: not provided) 100 F. On 11-APR-2021, the subject experienced muscle soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the soreness in arm, fever, headache, chills, body ache, fatigue and muscle soreness was not reported. This report was non-serious.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Heart rate, Heart rate increased
Clinical narrative: DIARRHEA; INCREASED PULSE; WEAKNESS; This spontaneous report received from a patient concerned a 73 year old male. The patient's height, and weight were not reported. The patient's past medical history included blood in brain, and concurrent conditions included headaches. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A,  expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. Concomitant medications included paracetamol for headaches.  On 12-APR-2021, the subject experienced increased pulse. On 12-APR-2021, the subject experienced weakness.  Laboratory data included: Pulse rate (NR: not provided) 110 (units unspecified).  On 14-APR-2021, the subject experienced diarrhea. On 15-APR-2021 05:36,  Laboratory data included: Pulse rate (NR: not provided) 87 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from increased pulse, and had not recovered from weakness, and diarrhea. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye swelling, Headache, Pain, Pyrexia
Clinical narrative: SHAKING UNCONTROLLABLY; FULL BODY ACHES EVERY WHERE, FEET, KNEES, SHOULDERS; SWOLLEN EYES; CHILLS; TERRIBLE HEADACHE; FEVER; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported, per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 12-APR-2021, the subject experienced shaking uncontrollably. On 12-APR-2021, the subject experienced full body aches every where, feet, knees, shoulders. On 12-APR-2021, the subject experienced swollen eyes. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced terrible headache. On 12-APR-2021, the subject experienced fever. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from terrible headache, chills, shaking uncontrollably, fever, full body aches every where, feet, knees, shoulders, and swollen eyes. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: SHAKING UNCONTROLLABLY; FULL BODY ACHES EVERY WHERE, FEET, KNEES, SHOULDERS; SWOLLEN EYES; CHILLS; TERRIBLE HEADACHE; FEVER; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported, per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 12-APR-2021, the subject experienced shaking uncontrollably. On 12-APR-2021, the subject experienced full body aches every where, feet, knees, shoulders. On 12-APR-2021, the subject experienced swollen eyes. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced terrible headache. On 12-APR-2021, the subject experienced fever. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from terrible headache, chills, shaking uncontrollably, fever, full body aches every where, feet, knees, shoulders, and swollen eyes. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: ADVERSE EVENT NOS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced adverse event nos. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adverse event nos was not reported. This report was non-serious. This case, from the same reporter is linked to 20210425196.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Testicular pain
Clinical narrative: SORE TENDER PAINFUL TESTICLES; HEADACHE; SORENESS IN ARM AT INJECTION SITE; This spontaneous report received from a consumer concerned a 36 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced soreness in arm at injection site. On 13-APR-2021, the subject experienced sore tender painful testicles. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and soreness in arm at injection site on APR-2021, and had not recovered from sore tender painful testicles. This report was non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Dizziness, Feeling hot
Clinical narrative: LOSS OF APPETITE; FEELING WARMER THAN USUAL; FEELING ACHY; FEELING SICK; WEAKNESS; CHILLS; HEADACHE; WOOZY/DIZZINESS; This spontaneous report received from a patient concerned a 40 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced woozy/dizziness. On 13-APR-2021, the subject experienced loss of appetite. On 13-APR-2021, the subject experienced feeling warmer than usual. On 13-APR-2021, the subject experienced feeling achy. On 13-APR-2021, the subject experienced feeling sick. On 13-APR-2021, the subject experienced weakness. On 13-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from feeling sick, headache, chills, loss of appetite, weakness, woozy/dizziness, feeling achy, and feeling warmer than usual. This report was non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise, Pain
Clinical narrative: LOSS OF APPETITE; FEELING WARMER THAN USUAL; FEELING ACHY; FEELING SICK; WEAKNESS; CHILLS; HEADACHE; WOOZY/DIZZINESS; This spontaneous report received from a patient concerned a 40 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced woozy/dizziness. On 13-APR-2021, the subject experienced loss of appetite. On 13-APR-2021, the subject experienced feeling warmer than usual. On 13-APR-2021, the subject experienced feeling achy. On 13-APR-2021, the subject experienced feeling sick. On 13-APR-2021, the subject experienced weakness. On 13-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from feeling sick, headache, chills, loss of appetite, weakness, woozy/dizziness, feeling achy, and feeling warmer than usual. This report was non-serious.